ES2645074T8 - Agentes antifúngicos y sus usos - Google Patents

Agentes antifúngicos y sus usos Download PDF

Info

Publication number
ES2645074T8
ES2645074T8 ES12751994.0T ES12751994T ES2645074T8 ES 2645074 T8 ES2645074 T8 ES 2645074T8 ES 12751994 T ES12751994 T ES 12751994T ES 2645074 T8 ES2645074 T8 ES 2645074T8
Authority
ES
Spain
Prior art keywords
antifungal agents
antifungal
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12751994.0T
Other languages
English (en)
Other versions
ES2645074T3 (es
Inventor
Kenneth Duke James, Jr.
Christopher Patrick Laudeman
Navdeep Balkrishna Malkar
Balasingam Radhakrishnan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cidara Therapeutics Inc
Original Assignee
Cidara Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cidara Therapeutics Inc filed Critical Cidara Therapeutics Inc
Application granted granted Critical
Publication of ES2645074T3 publication Critical patent/ES2645074T3/es
Publication of ES2645074T8 publication Critical patent/ES2645074T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES12751994.0T 2011-03-03 2012-03-02 Agentes antifúngicos y sus usos Active ES2645074T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161448807P 2011-03-03 2011-03-03
US201161448807P 2011-03-03
PCT/US2012/027451 WO2012119065A2 (en) 2011-03-03 2012-03-02 Antifungal agents and uses thereof

Publications (2)

Publication Number Publication Date
ES2645074T3 ES2645074T3 (es) 2017-12-04
ES2645074T8 true ES2645074T8 (es) 2018-09-28

Family

ID=46758514

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12751994.0T Active ES2645074T3 (es) 2011-03-03 2012-03-02 Agentes antifúngicos y sus usos

Country Status (20)

Country Link
US (5) US8722619B2 (es)
EP (2) EP2680873B1 (es)
JP (4) JP5809296B2 (es)
CN (2) CN103889221B (es)
CA (2) CA2865791C (es)
CY (1) CY1119709T1 (es)
DK (1) DK2680873T3 (es)
ES (1) ES2645074T3 (es)
FI (1) FIC20240022I1 (es)
FR (1) FR24C1027I1 (es)
HR (1) HRP20171579T8 (es)
HU (2) HUE036778T2 (es)
LT (1) LT2680873T (es)
NL (1) NL301280I2 (es)
NO (1) NO2680873T3 (es)
PL (1) PL2680873T3 (es)
PT (1) PT2680873T (es)
RS (1) RS56426B1 (es)
SI (1) SI2680873T1 (es)
WO (1) WO2012119065A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2680873B1 (en) 2011-03-03 2017-08-09 Cidara Therapeutics, Inc. Antifungal agents and uses thereof
CN104507309B (zh) * 2012-03-19 2017-05-03 奇达拉治疗公司 用于棘白菌素类化合物的给药方案
US20160213742A1 (en) * 2013-09-04 2016-07-28 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
WO2015167989A1 (en) * 2014-04-28 2015-11-05 University Of Central Florida Research Foundation, Inc. Compositions, methods of making a composition, and methods of use
WO2016201283A1 (en) * 2015-06-12 2016-12-15 Cidara Therapeutics, Inc. Antifungal agents
WO2017049102A1 (en) * 2015-09-16 2017-03-23 Cidara Therapeutics, Inc. Methods for treating fungal infections
CN106674333B (zh) * 2015-11-06 2020-10-27 博瑞生物医药(苏州)股份有限公司 一种环肽类抗真菌化合物及其制备方法
WO2017120471A1 (en) * 2016-01-08 2017-07-13 Cidara Therapeutics, Inc. Methods for preventing and treating pneumocystis infections
JP7224916B2 (ja) * 2016-03-16 2023-02-20 シダラ セラピューティクス インコーポレーテッド 真菌感染の処置のための投薬レジメン
WO2018102407A1 (en) * 2016-11-29 2018-06-07 Cidara Therapeutics, Inc Methods for preventing fungal infections
MA47437A (fr) * 2017-01-31 2019-12-11 Cidara Therapeutics Inc Procédés de traitement d'infections fongiques
EP3651801A4 (en) 2017-07-12 2021-04-07 Cidara Therapeutics, Inc. COMPOSITIONS AND METHODS OF TREATMENT OF MUSHROOM INFECTION
US11524980B2 (en) 2018-06-15 2022-12-13 Cidara Therapeutics, Inc. Synthesis of echinocandin antifungal agent
WO2020086931A1 (en) * 2018-10-25 2020-04-30 Cidara Therapeutics, Inc. Polymorph of echinocandin antifungal agent
CN114616238A (zh) 2019-12-06 2022-06-10 上海森辉医药有限公司 棘白菌素类似物及其制备方法
US20240262866A1 (en) 2021-06-03 2024-08-08 Shanghai Senhui Medicine Co., Ltd. Method for preparing anidulafungin derivative
CN116903706B (zh) * 2023-06-13 2024-05-17 深圳市祥根生物有限公司 一种棘白菌素类药物及其制备方法和用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030944A (en) * 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
US5399552A (en) 1991-10-17 1995-03-21 Merck & Co, Inc Antibiotic peptides bearing aminoalkylthioether moieties
US5378804A (en) 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US6268338B1 (en) 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
WO1994025045A1 (en) * 1993-05-04 1994-11-10 Merck & Co., Inc. Cyclohexapeptidyl aminoalkyl ethers
US5948753A (en) 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
WO1995008341A1 (en) * 1993-09-22 1995-03-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5541160A (en) * 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5514651A (en) * 1994-09-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5516756A (en) 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
DE69615535T2 (de) 1995-01-26 2002-05-02 Merck & Co., Inc. Neue fungizide cyclohexapeptide
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
ES2272096T3 (es) * 1998-12-09 2007-04-16 Eli Lilly And Company Purificacion de compuestos ciclopeptidicos de equinocandina.
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1345230A (zh) 1999-03-03 2002-04-17 伊莱利利公司 口服ecb药物制剂和药物组合物的制备方法
US6610822B2 (en) 2000-09-01 2003-08-26 Merck & Co., Inc. Purification process
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
ATE381957T1 (de) * 2003-07-22 2008-01-15 Theravance Inc Verwendung eines antimykotischen echinocandin- mittels in kombination mit einem antibakteriellen glycopeptid-mittel
US20070231258A1 (en) * 2006-03-31 2007-10-04 Karyon Ctt Ltd. Peptide conjugates
US20090238867A1 (en) 2007-12-13 2009-09-24 Scott Jenkins Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
GB0817121D0 (en) 2008-09-18 2008-10-29 Univ St Andrews Anti-fungal therapy
US9006391B2 (en) * 2009-05-07 2015-04-14 Dsm Sinochem Pharmaceuticals Netherlands B.V. Method for the preparation of cyclopeptides
WO2011025875A1 (en) 2009-08-27 2011-03-03 Seachaid Pharmaceuticals, Inc. Echinocandin derivatives
US9561285B2 (en) 2010-01-22 2017-02-07 Ascendis Pharma As Carrier-linked carbamate prodrug linkers
EP2680873B1 (en) 2011-03-03 2017-08-09 Cidara Therapeutics, Inc. Antifungal agents and uses thereof

Also Published As

Publication number Publication date
JP2017132770A (ja) 2017-08-03
PT2680873T (pt) 2017-11-01
LT2680873T (lt) 2017-11-27
US9217014B2 (en) 2015-12-22
JP6302108B2 (ja) 2018-03-28
CN106279369A (zh) 2017-01-04
EP3192803B1 (en) 2020-12-09
DK2680873T3 (en) 2017-10-30
FR24C1027I1 (fr) 2024-08-30
US20130244930A1 (en) 2013-09-19
JP5809296B2 (ja) 2015-11-10
HRP20171579T8 (hr) 2018-12-14
WO2012119065A2 (en) 2012-09-07
US20220162263A1 (en) 2022-05-26
JP2014516339A (ja) 2014-07-10
CA2865791C (en) 2019-10-08
JP2018118977A (ja) 2018-08-02
FIC20240022I1 (fi) 2024-06-19
ES2645074T3 (es) 2017-12-04
WO2012119065A3 (en) 2014-03-13
CA2865791A1 (en) 2012-09-07
HUE036778T2 (hu) 2018-07-30
US9676821B2 (en) 2017-06-13
CN106279369B (zh) 2020-02-11
US20150024997A1 (en) 2015-01-22
SI2680873T1 (sl) 2017-12-29
US20170253635A1 (en) 2017-09-07
NL301280I2 (nl) 2024-08-01
NO2680873T3 (es) 2018-01-06
PL2680873T3 (pl) 2018-01-31
RS56426B1 (sr) 2018-01-31
CN103889221B (zh) 2016-08-31
EP2680873A2 (en) 2014-01-08
HUS2400021I1 (hu) 2024-07-28
HRP20171579T1 (hr) 2018-02-09
CN103889221A (zh) 2014-06-25
CY1119709T1 (el) 2018-06-27
CA3053850A1 (en) 2012-09-07
EP3192803A1 (en) 2017-07-19
US8722619B2 (en) 2014-05-13
JP6111447B2 (ja) 2017-04-12
EP2680873B1 (en) 2017-08-09
JP2016029052A (ja) 2016-03-03
EP2680873A4 (en) 2015-08-26
US20160075740A1 (en) 2016-03-17

Similar Documents

Publication Publication Date Title
ES2645074T8 (es) Agentes antifúngicos y sus usos
CO7030961A2 (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
CO6980627A2 (es) Anticuerpos anti-pfh-tau y sus usos
CO6821892A2 (es) Anticuerpos anti-angptl3 y usos de los mismos
CO6880072A2 (es) Compuestos de n-tio-antranilamida y sus usos como plaguicidas
CO6870031A2 (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
DK3597644T3 (da) Kationiske aminlipider og anvendelser deraf
BR112014012137A2 (pt) anticorpos anti-fgfr2 e suas utilizações
DK2684610T4 (da) Bruser
BR112014002341A2 (pt) artigo gráfico
CO6801713A2 (es) Heteroarilos y sus usos
BR112014002340A2 (pt) artigo gráfico
CO7091181A2 (es) Compuestos heterociclicos y sus usos
DK3392252T3 (da) Pyrimido-pyridazinonforbindelser og deres anvendelse
SMT201600441B (it) Nuovi agenti antimalarici
CO6880071A2 (es) Compuestos de antranilamida y sus usos como plaguicidas
BR112015007217A2 (pt) compostos e usos do composto
CO6862154A2 (es) Metabolitos de trans-clomifeno y usos de los mismos
CO6880073A2 (es) Compuestos de antranilamida y sus usos como plaguicidas
BR112013033919A2 (pt) combinações e seus usos
BR112014027183A2 (pt) 6-piridona-2-carbamoilazoles e sua utilização como herbicidas
DK3056606T3 (da) Håndstopper
DE112013002592A5 (de) Beschichtungsmittel
BR112014021674A2 (pt) arilpirrolidinas pesticidas
FR2978106B1 (fr) Voilure amovible